Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Synthetic Biologics Inc (SYN)

Synthetic Biologics Inc (SYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Synthetic Biologics Inc 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 USA

www.syntheticbiologics.com P: 301-417-4364

Description:

Synthetic Biologics, Inc. is a biotechnology company focused on the development of synthetic DNA-based therapeutics and innovative disease-modifying medicines for serious illnesses. The Company is engaged in developing product candidates to treat pulmonary arterial hypertension, relapses in multiple sclerosis, cognitive dysfunction in multiple sclerosis, fibromyalgia and amyotrophic lateral sclerosis. Synthetic Biologics, Inc., formerly known as Adeona Pharmaceuticals, Inc., is headquartered in Ann Arbor, Michigan.

Key Statistics

Overview:

Market Capitalization, $K 16,161
Enterprise Value, $K -51,169
Shares Outstanding, K 15,844
Annual Sales, $ 0 K
Annual Net Income, $ -14,270 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -4,968 K
60-Month Beta 1.38
% of Insider Shareholders 2.15%
% of Institutional Shareholders 74.38%
Float, K 15,503
% Float 97.85%
Short Volume Ratio 0.57

Growth:

1-Year Return -76.98%
3-Year Return -74.44%
5-Year Return -99.68%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 98.13%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.31 on 08/11/22
Latest Earnings Date 11/02/22
Earnings Per Share ttm -1.01
EPS Growth vs. Prev Qtr -3.33%
EPS Growth vs. Prev Year -55.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 07/25/22

SYN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -26.77%
Return-on-Assets % -22.44%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.26
Book Value/Share 0.00
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar